2008: B-Cell Biology and Targets in Autoimmune Disease
Search or Browse by Day

B-Cell Biology and Targets in Autoimmune Disease

Monday, October 27, 2008
740
ΔBAFF, a Diagnostic Tool in the Early Events of Autoimmunity
741
Positive Feedback of Autoantibodies, Immune Complexes, and Spontaneous Germinal Centers Through An AID-Dependent Mechanism
742
Structural and Thermodynamic Basis of Peptide Immunogenicity: Profiling of Histidyl-tRNA Synthetase Epitopes
743
Inhibition of B Cell Receptor-Mediated B Cell Activation by Coengagement of CD19 and FcγRIIb with Fc-Engineered Antibodies
744
Identification and characterization of human CD5+ pre-naive B cell population
745
B Cells Drive Lymphocyte Activation And Expansion In Mice With The Cd45 Wedge Mutation And Fas Deficiency
746
Role of Transcription Factor Fli-1 in Ig Production and Class Switching
747
TNFa Blockade Impairs T Cell Dependent Antibody Responses
748
Bone Marrow Plasma Cell Memory Is Extremely Refractory To Immunosuppressive Therapy
749
Title:Repopulation of IgD+CD27+ Memory B Cells after Rituximab: Delayed Acquisition of Mutations in Single B cell Ig Receptors
750
Rituximab (RTX) may complex with IgMκ Mixed Cryoglobulin (MC) and induce severe systemic reactions in patients with Hepatitis C virus (HCV) vasculitis
751
Differential Effects of IL-17 and IL-23 in Stabilization of Spontaneous Germinal Centers in the Spleens of Autoimmune BXD2 Mice
752
IVIG-ID Is Not Affecting The Plasma Cell Compartment In Young And Old NZB/W Mice
753
Characterization of human late transitional B cells: Implications for systemic lupus
754
Ro60 Expresses an SLE-specific Neo-epitope During Apoptosis
755
CD5-Induced Loss of B Cell Tolerance is Influence by DNA Methylation in Lupus
756
Multipotent Mesenchymal Stromal Cells: Potential Therapeutic Use In An Animal Model Of Systemic Lupus Erythematosus
757
Increased Expression of BCMA on Systemic Lupus Erythematosus B Cells is Associated with Enhanced Response to BLyS and APRIL
758
Genetic Association of C8orf13/BLK Locus in Systemic Lupus Erythematosus
759
In Situ B cell mediated immune responses and tubulointerstitial inflammation in human lupus nephritis
760
BLyS/APRIL Heterotrimers Activate Human B Cells, are Elevated in SLE and RA Patient Sera, and are Neutralized by Atacicept
761
The Effect of Gender, Rheumatoid Arthritis (RA) and Biologic Therapy on Anti-Phosphorylcholine Antibody (APCA) Levels
762
ACR And DAS 28 Response Over 24 Weeks In RA Patients Treated With Rituximab After An Inadequate Response To One TNF Inhibitor
763
VCAM-1 Expression on The Surface of RA Synovial Fibroblasts (RASfib) upregulates B cell IL-15 receptor alpha, beta and gamma chain expression
764
Altered Circulating Cytokine Pattern after Administration of Rituximab is Correlated with Response to Therapy in Rheumatoid Arthritis
765
Persistent Generation of Plasmablasts in B cell depleted Patients with Rheumatoid Arthritis
766
Circulating Activated B Cells and Clinical Response to Rituxmab in RA
767
Clinical Relapse in Rituximab Treated Rheumatoid Arthritis Patients is B Cell Maturation Stage-Dependent
768
Synovial CXCL13 Expression is Associated with Localized Inflammation and Predicts Synovial Response to Rituximab in Rheumatoid Arthritis
769
Synovial B Cells Of Rheumatoid Arthritis Express Zap-70 Which Increases The Survival And Correlates With The Inflammatory And Autoimmune Phenotype
770
Nucleosomes, But Not Type I Interferons, Contribute To the Induction Of Anti-nuclear Antibodies By TNF Alpha Blockade In Spondyloarthritis
771
Neutralization Of CXCL13 Impacts B-cell Trafficking And Reduces Severity Of Established Experimental Arthritis
772
Non-lymphoid Expression of B7-H1 Regulates Severity of Proteoglycan-Induced Arthritis
1190
Prospective Follow-up Of Rituximab Treatment In 965 Patients With Refractory Rheumatoid Arthritis (630 Patients/year) : Tolerance And Efficacy Data From The French Registry Air (autoimmunity And Rituximab)
1191
Effects Of Rituximab On Global Gene Expression Profiles In Synovial Biopsies Obtained From Rheumatoid Arthritis Patients
1192
CD19 Regulates the Development of Bleomycin-induced Pulmonary Fibrosis
1193
CD180 (Rp105) Functional Interactions with TLR4 and BCR
1194
Ro60 Functions as a Receptor for Beta2-glycoprotein I on Apoptotic Cells
1195
IL-17 upregulates RGS16 and RGS13 through the Canonical NF-κB Signaling Pathway in Autoimmune B Cells of BXD2 mice
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>